Ranelic Acid

Summary

Ranelic Acid (CHEMBL2107175) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 342.28 Da · C12H10N2O8S

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL2107175
Name	Ranelic Acid
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	3052774
Molecular formula	C12H10N2O8S
Molecular weight	342.28
InChIKey	DJSXNILVACEBLP-UHFFFAOYSA-N

SMILES: C(C1=C(SC(=C1C#N)N(CC(=O)O)CC(=O)O)C(=O)O)C(=O)O

IUPAC name: 5-[bis(carboxymethyl)amino]-3-(carboxymethyl)-4-cyanothiophene-2-carboxylic acid

Also known as: Acide ranelique, Acido ranelico, Ranelic acid, S-12911, S12911, RANELIC ACID

Parent form; salt/anhydrous children: CHEMBL3182450, CHEMBL3707306

Patent coverage: 116 distinct patent families (387 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indications (0 at ChEMBL trial phase 4).

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).